Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development

Loading news article.

Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development | WAPE

Reported Earlier, Humacyte Prices Public Offering Of 47,619,048 Common Shares At $1.05 Per Share Raising $50M To Fund Symvess Commercialization And Pipeline Development

Article summary

Related companies

Comments —